Perrigo Company plc (NYSE:PRGO – Get Free Report) declared a quarterly dividend on Thursday, October 29th. Investors of record on Friday, November 27th will be paid a dividend of $0.29 per share on Tuesday, December 15th. This represents a $1.16 annualized dividend and a dividend yield of 7.3%. The ex-dividend date is Friday, November 27th.
Perrigo has increased its dividend by an average of 0.1% annually over the last three years and has increased its dividend every year for the last 23 years. Perrigo has a dividend payout ratio of 35.5% indicating that its dividend is sufficiently covered by earnings. Analysts expect Perrigo to earn $2.35 per share next year, which means the company should continue to be able to cover its $1.16 annual dividend with an expected future payout ratio of 49.4%.
Perrigo Price Performance
PRGO stock opened at $15.85 on Friday. The stock has a 50-day moving average price of $14.78 and a two-hundred day moving average price of $12.47. The company has a market cap of $2.20 billion, a PE ratio of -1.27, a price-to-earnings-growth ratio of 1.83 and a beta of 0.69. The company has a current ratio of 2.32, a quick ratio of 1.32 and a debt-to-equity ratio of 1.31. Perrigo has a 12-month low of $9.23 and a 12-month high of $21.33.
Analyst Upgrades and Downgrades
Several research analysts have recently issued reports on the company. Weiss Ratings upgraded Perrigo from a “sell (d-)” rating to a “sell (d)” rating in a research report on Thursday, August 6th. Wall Street Zen downgraded shares of Perrigo from a “strong-buy” rating to a “buy” rating in a report on Sunday, September 27th. One analyst has rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $17.50.
Get Our Latest Analysis on PRGO
Perrigo Company Profile
Perrigo Company plc is a global consumer self-care company that develops, manufactures and markets over-the-counter health products, wellness products and personal care items. Its portfolio includes products for allergy, pain relief, digestive health, skin care, smoking cessation, women’s health and other everyday health needs, along with vitamins, nutritional supplements and infant nutrition products.
Perrigo supplies products under its own brands, acquired brands and retailer-owned private-label labels.
Featured Articles
- Five stocks we like better than Perrigo
- Chipotle’s $32 Floor: Is a Major Stock Rebound Coming?
- SaaS-Pocalypse II: Is ServiceNow’s Sell-Off Another Buying Opportunity?
- Robinhood Stock Is Down Nearly 37%—So Why Is Wall Street Still So Bullish?
- 5 Stocks to Buy in November: Bargains Worth Giving Thanks For
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.
